206 related articles for article (PubMed ID: 20486460)
21. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
Muñoz CM; Sánchez JL; Martín-García RF
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
[TBL] [Abstract][Full Text] [Related]
22. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
Ezughah FI; Affleck AG; Evans A; Ibbotson SH; Fleming CJ
J Dermatolog Treat; 2008; 19(3):156-8. PubMed ID: 18569271
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
Marks R; Owens M; Walters SA;
Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
[No Abstract] [Full Text] [Related]
25. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
[No Abstract] [Full Text] [Related]
26. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.
Weisberg NK; Varghese M
Dermatol Surg; 2002 Jun; 28(6):518-23. PubMed ID: 12081683
[TBL] [Abstract][Full Text] [Related]
27. Imiquimod to treat basal cell and squamous cell carcinomas.
Keller CD
Am Fam Physician; 2005 Jul; 72(1):41. PubMed ID: 16035682
[No Abstract] [Full Text] [Related]
28. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Navi D; Huntley A
Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
[TBL] [Abstract][Full Text] [Related]
29. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
Konstantopoulou M; Lord MG; Macfarlane AW
Dermatol Online J; 2006 Mar; 12(3):10. PubMed ID: 16638424
[TBL] [Abstract][Full Text] [Related]
30. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
Schiessl C; Wolber C; Tauber M; Offner F; Strohal R
J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
[TBL] [Abstract][Full Text] [Related]
31. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
32. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
[TBL] [Abstract][Full Text] [Related]
33. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
Tillman DK; Carroll MT
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
[TBL] [Abstract][Full Text] [Related]
34. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
Yang JQ; Chen XY; Engle MY; Wang JY
Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma.
Asakura M; Miura H
Dermatol Ther; 2011; 24(3):375-7. PubMed ID: 21689248
[TBL] [Abstract][Full Text] [Related]
36. The treatment of viral infections and nonmelanoma skin cancers.
Del Rosso JQ
Cutis; 2007 Apr; 79(4 Suppl):29-35. PubMed ID: 17508493
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
38. Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
Peters-Kennedy J; Scott DW; Miller WH
J Feline Med Surg; 2008 Dec; 10(6):593-9. PubMed ID: 18417398
[TBL] [Abstract][Full Text] [Related]
39. Invasive squamous cell carcinoma treated with imiquimod 5% cream.
Flórez A; Feal C; de la Torre C; Cruces M
Acta Derm Venereol; 2004; 84(3):227-8. PubMed ID: 15202841
[No Abstract] [Full Text] [Related]
40. Role of imiquimod in skin cancer treatment.
Urosevic M; Dummer R
Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
